600587 Shinva Medical Instrument
- 23.60
- -0.20-0.84%
Shinva Medical Instrument News
Xinhua Healthcare (600587.SH) subsidiary received a medical device registration certificate
Xinhua Medical (600587.SH) announced that the company's subsidiary Shanghai Tianqing Biomaterials Co., Ltd. recently received the national...
Xinhua Healthcare (600587.SH): Net profit of 211 million yuan in the first quarter increased 7.39% year over year
Gelonghui, April 29丨Xinhua Healthcare (600587.SH) released its report for the first quarter of 2024, achieving operating income of 2,529 billion yuan, an increase of 3.68%; net profit attributable to shareholders of listed companies of 211 million yuan, an increase of 7.39% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss of 209 million yuan, an increase of 13.77% year on year; and basic earnings per share of 0.45 yuan.
Investors Aren't Entirely Convinced By Shinva Medical Instrument Co.,Ltd.'s (SHSE:600587) Earnings
With a price-to-earnings (or "P/E") ratio of 14.8x Shinva Medical Instrument Co.,Ltd. (SHSE:600587) may be sending very bullish signals at the moment, given that almost half of all companies in China
Xinhua Healthcare (600587.SH) issued 2023 annual results, with net profit of 654 million yuan, an increase of 30.78% over the previous year. It plans to transfer 5 yuan for every 10 shares to increase 3 shares
Xinhua Healthcare (600587.SH) released its 2023 annual report. The company achieved an operating income of 10 during the reporting period...
Shinva Medical InstrumentLtd's (SHSE:600587) Three-year Earnings Growth Trails the Respectable Shareholder Returns
By buying an index fund, you can roughly match the market return with ease. But if you buy good businesses at attractive prices, your portfolio returns could exceed the average market return. For ex
Shinva Medical InstrumentLtd (SHSE:600587) Could Easily Take On More Debt
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the permanent loss of capital.' When we think about how risky a company is, we always like
Shinva Medical InstrumentLtd (SHSE:600587) May Have Issues Allocating Its Capital
If you're looking for a multi-bagger, there's a few things to keep an eye out for. One common approach is to try and find a company with returns on capital employed (ROCE) that are increasing, in con
Xinhua Healthcare (600587.SH) received a medical device registration certificate
Xinhua Medical (600587.SH) announced that the company received the “Medical Devices...” issued by the Shandong Drug Administration
Both Retail Investors Who Control a Good Portion of Shinva Medical Instrument Co.,Ltd. (SHSE:600587) Along With Institutions Must Be Dismayed After Last Week's 3.8% Decrease
Key Insights The considerable ownership by retail investors in Shinva Medical InstrumentLtd indicates that they collectively have a greater say in management and business strategy A total of 10 inve
Insufficient Growth At Shinva Medical Instrument Co.,Ltd. (SHSE:600587) Hampers Share Price
When close to half the companies in China have price-to-earnings ratios (or "P/E's") above 35x, you may consider Shinva Medical Instrument Co.,Ltd. (SHSE:600587) as an attractive investment with its 1
Shinva Medical InstrumentLtd (SHSE:600587) Sheds 4.5% This Week, as Yearly Returns Fall More in Line With Earnings Growth
Stock pickers are generally looking for stocks that will outperform the broader market. And the truth is, you can make significant gains if you buy good quality businesses at the right price. For ex
Xinhua Medical (600587.SH) plans to establish a subsidiary specializing in radiological diagnosis and treatment products
Xinhua Healthcare (600587.SH) announced that in order to introduce external resources such as talents and technology, achieve institutional innovation, and deepen cultivation...
Xinhua Healthcare (600587.SH): Plans to transfer 80,000 common shares and 1.2 million preferred shares of EMT's shares for HK$20.35 million
Gelonghui November 27丨Xinhua Medical (600587.SH) announced that the company plans to transfer 80,000 common shares and 1.2 million preferred shares of Eastwood Medical Trading Co., Ltd. (hereinafter referred to as “EMT Company”) held by Huatuo International Development Co., Ltd. (“Huatuo International”), a wholly-owned subsidiary of the company, to natural person Zhu Guodong at a price of HK$20.35 million. After the equity transfer is completed, Huatuo International no longer holds shares in EMT. EMT was founded in 2012/3, and the end of the project
Xinhua Medical (600587.SH): Metal bone needles obtained three types of medical device registration certificates
Gelonghui November 21丨Xinhua Medical (600587.SH) announced that its subsidiary Xinhua Surgical Instruments Co., Ltd. has received the “Medical Device Registration Certificate of the People's Republic of China” issued by the State Drug Administration. Product name: Metal Bone Needle. Metal bone needles are Class III orthopedic implants. They are the most widely used products among orthopedic implant consumables. They are used for partial implantation in human traction or internal fixation for limb fractures during orthopedic limb fractures, and have high market value and promotion.
Is Shinva Medical InstrumentLtd (SHSE:600587) A Risky Investment?
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says 'The biggest investment risk is not the volatility of prices, but whether you will
Hyde Control (002184.SZ): Major cooperative enterprises in the intelligent pharmaceutical equipment industry include Dongfulong, Chutian Technology, Zhejiang Tailin, and Xinhua Medical
On October 31, Gelonghui, Hyde Control (002184.SZ) stated on the investor interactive platform that the industrial informatization business, one of the company's main businesses, mainly provides safe and reliable automation, information product services, and automation and information technology integration system solutions for users in pharmaceutical and other industries. The company's main partners in the intelligent pharmaceutical equipment industry include Dongfulong, Chutian Technology, Zhejiang Tailin, and Xinhua Medical.
The Returns On Capital At Shinva Medical InstrumentLtd (SHSE:600587) Don't Inspire Confidence
Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key financial metrics. Firstly, we'd want to identify a growing return on capital e
[Instant Analysis of BT Financial Report] Xinhua Medical's 2023 Third Quarter Report: Excellent balance and liability performance, continuous growth in operating income and net profit
Announcement time of this financial report: 2023-10-24 16:19:23 Xinhua Healthcare (stock code: 600587) is a company focusing on medical devices and pharmaceutical equipment. The business structure is “2+2,” that is, the two core businesses of medical commerce and medical services. In the medical device sector, the company is guided by customer needs and expands related product lines based on its own technology accumulation. Its product technology is in an advantageous position in China, and its market share ranks among the highest in the domestic industry. In terms of assets and liabilities, Xinhua Medical's total assets for the third quarter of 2023 were 14.482 billion yuan, compared to the end of the previous year
Jinan Medical Management, a subsidiary of Xinhua Medical (600587.SH) holding company, plans to increase capital and expand shares to bring in strategic investors
Xinhua Healthcare (600587.SH) issued an announcement. Jinan Xinhua Hospital Investment Management Co., Ltd., a holding subsidiary of the company...
Xinhua Healthcare (600587.SH): Net profit for the third quarter was 120 million yuan, up 22.88% year on year
Glonghui, Oct. 24, 丨 Xinhua Healthcare (600587.SH) announced its report for the third quarter of 2023. Operating income for the reporting period was 2,244 million yuan, up 1.29% year on year; net profit attributable to shareholders of listed companies was 120 million yuan, up 22.88% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 144 million yuan, up 76.04% year on year; basic earnings per share were 0.26 yuan/share.
Analysis
Price Target
No Data
